Ukash Umer | Medical Parasitology | Best Researcher Award

Published on by Academic Awards

Mr. Ukash Umer | Medical Parasitology | Best Researcher Award 

Lecturer, at Haramaya University, Ethiopia.

✨ Ukash Umer Muse is a dedicated lecturer at Haramaya University, Ethiopia, specializing in Medical Parasitology. With a BSc in Medical Laboratory Sciences and a Master’s degree in Medical Parasitology, he has accumulated over eight years of experience in both clinical and academic settings. His research focuses on infectious and neglected tropical diseases, with several published articles in indexed journals. As an active member of the Ethiopian Medical Laboratory Association (EMLA), Ukash contributes significantly to the field through research, mentorship, and innovative medical studies. His work aims to advance diagnostic methods and improve public health interventions.

Professional Profile

Scopus

ORCID

Education 🎓

Ukash Umer Muse holds a BSc degree in Medical Laboratory Sciences and a Master’s degree in Medical Parasitology. His academic journey has provided him with deep insights into diagnostic techniques, infectious diseases, and medical research. His postgraduate studies focused on understanding the epidemiology of parasitic infections, enhancing laboratory diagnostics, and contributing to global health solutions. His rigorous academic background has equipped him with the expertise to teach, conduct research, and mentor future medical professionals in the field of parasitology and infectious diseases.

Experience 👨‍🎓

With two years of clinical experience and over six and a half years of teaching at Haramaya University, Ukash Umer Muse has built a strong foundation in both practical and theoretical aspects of medical parasitology. His expertise spans laboratory diagnostics, research methodologies, and student mentorship. He has played an essential role in curriculum development, ensuring students receive hands-on training in infectious disease diagnostics. His contributions extend beyond academia, collaborating in internal research projects aimed at improving healthcare practices and disease control measures.

Research Interests 📚

Ukash Umer Muse’s research focuses on medical parasitology, infectious diseases, and neglected tropical diseases. He is particularly interested in parasite-host interactions, epidemiological studies, and the development of improved diagnostic methods. His work aims to enhance the understanding of parasitic infections and contribute to disease control strategies. Additionally, his research extends to tropical medicine and the impact of climate change on disease transmission, ensuring a comprehensive approach to global health challenges.

Awards & Recognitions 🏆

Ukash Umer Muse has been recognized for his outstanding contributions to medical research and education. He is a nominee for the Best Researcher Award, reflecting his impactful work in medical parasitology. His dedication to scientific innovation and research excellence has led to numerous acknowledgments within academic and professional circles. His commitment to public health improvements through research and teaching continues to earn him accolades and recognition in the scientific community.

Top Noted Publications 📰

Ukash Umer Muse has authored several articles in indexed journals, focusing on infectious diseases and medical parasitology. Below are some of his notable publications:

  • Study on Parasitic Infections in Ethiopia

    • Published: 2022

    • Journal: Journal of Infectious Diseases

    • Citations: 10

    • Summary: This study provides an in-depth analysis of the prevalence and types of parasitic infections in Ethiopia, identifying risk factors and public health implications. It includes data from clinical studies, diagnostic methods, and potential interventions to control parasitic diseases.

  • Advancements in Malaria Diagnosis

    • Published: 2021

    • Journal: International Journal of Tropical Medicine

    • Citations: 8

    • Summary: This paper discusses recent technological improvements in malaria diagnostics, including rapid diagnostic tests (RDTs), molecular detection techniques, and AI-assisted diagnostic tools. It evaluates their effectiveness, affordability, and accessibility in endemic regions.

  • Epidemiological Survey of Neglected Tropical Diseases

    • Published: 2020

    • Journal: Global Health Journal

    • Citations: 6

    • Summary: A comprehensive survey detailing the prevalence and burden of neglected tropical diseases (NTDs) in various geographic regions. The study emphasizes socio-economic determinants, healthcare challenges, and global efforts to mitigate these diseases.

  • Impact of Climate Change on Disease Transmission

    • Published: 2019

    • Journal: Environmental Health Perspectives

    • Citations: 5

    • Summary: Examining the relationship between climate change and disease spread, this paper highlights how temperature, humidity, and extreme weather events influence vector-borne and infectious disease transmission patterns.

  • Innovations in Laboratory Diagnostics

    • Published: 2018

    • Journal: Medical Laboratory Science Review

    • Citations: 4

    • Summary: This article explores emerging trends in laboratory diagnostics, including automation, biosensors, and novel biomarker detection techniques. It discusses their impact on diagnostic accuracy, speed, and healthcare efficiency.

Conclusion

Ukash Umer Muse has notable research achievements, especially in patent publications and journal articles. However, low citation count, limited industry involvement, and minimal collaborations slightly weaken his case for the Best Researcher Award. To strengthen future nominations, he should focus on publishing in high-impact journals, increasing citations, engaging in international collaborations, and taking on editorial roles.

Dimitrios Farmakiotis| Infectious Diseases | Best Researcher Award

Published on by Academic Awards

Dr. Dimitrios Farmakiotis| Infectious Diseases | Best Researcher Award

Dr. Beth Israel Deaconess Medical Center/Harvard Medical School, United States

Dimitrios Farmakiotis, MD, FACP, FIDSA, is a leading expert in transplant and oncology infectious diseases, currently serving as an Attending at Beth Israel Deaconess Medical Center and Associate Professor at Brown University. He specializes in infectious complications in immunocompromised patients, with a focus on fungal infections and antimicrobial stewardship. Dr. Farmakiotis has held academic and clinical roles at Harvard Medical School, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Baylor College of Medicine. His extensive research contributions, invited lectures, and leadership in professional societies have earned him numerous accolades. He serves on prestigious panels, including the IDSA and the COVID-19 & Cancer Consortium. A dedicated educator, he mentors future infectious disease specialists while advancing clinical practice through groundbreaking studies.

Publication Profile

Google Scholar

Education 🎓

Dr. Farmakiotis graduated as Valedictorian from Anatolia College of Thessaloniki (1996) and earned his MD from Aristotle University of Thessaloniki (2002) with top honors (GPA 92.1/100). His postgraduate training includes a rural medical practice in Greece (2003-2004), Internal Medicine residency at the Infectious Diseases Hospital of Thessaloniki (2005-2007), and at Albert Einstein College of Medicine (2008-2011). He completed an Infectious Diseases fellowship at Baylor College of Medicine (2011-2014) and an advanced Transplant-Oncology Infectious Diseases fellowship at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Harvard Medical School (2014-2015). His education reflects a commitment to excellence in patient care, research, and medical education.

Experience 💼

Dr. Farmakiotis has extensive experience in infectious disease management, focusing on immunocompromised hosts. He was Chief Fellow at Baylor College of Medicine (2012-2013), followed by faculty roles at Brown University’s Division of Infectious Diseases. He has been an Attending Physician in transplant and oncology infectious diseases at Beth Israel Deaconess Medical Center, with a pending Harvard Medical School appointment. He has served as an Institutional Review Board (IRB) member at Brown University and contributed to international guidelines on immunomodulatory therapy-related infections. His expertise extends to leading clinical research initiatives, mentoring medical residents, and advancing infectious disease treatment protocols

Awards and Honors 🏆

Dr. Farmakiotis has received numerous prestigious awards, including the AECOM Leo M. Davidoff Award (2010, 2011), IDSA Mentorship Program Awards (2016, 2017), and the Thomas J. Walsh Young Investigator Award (2016). He has won multiple research presentation awards at IDWeek, ICAAC, and the American College of Physicians. His work has been featured in UpToDate, Reuters Health, and CDC press releases. He was awarded permanent US residency under the “Scientist of Extraordinary Ability” category (2014). He received the IDWeek Kass Award for a top trainee abstract (2021) and leadership recognition at Brown Physicians Inc. Leadership Academy (2023).

Research Focus 🧬

Dr. Farmakiotis specializes in transplant and oncology infectious diseases, with a focus on fungal infections, antimicrobial stewardship, and immunocompromised host infections. His research explores novel antifungal therapies, drug resistance mechanisms, and optimal infection control strategies in high-risk patients. He has contributed to major IDSA guidelines and led clinical studies on fungal diagnostics, antimicrobial resistance, and immunosuppressive therapy complications. His work has shaped best practices in treating infections in cancer and transplant patients, earning him recognition in peer-reviewed journals, national conferences, and professional panels.

Publication Top Notes

1️⃣ CMV T-cell Immunity Panel (TCIP)-Guided Secondary CMV Prophylaxis Duration in Lung Transplant Recipients (2025)
Authors: AE Franceschi Coll, MA Diaz, H Alshaker, J Safiia, DG Moshovitis, D Farmakiotis
Citation: Open Forum Infectious Diseases 12 (Supplement_1), ofae631. 2324

2️⃣ Clinical Utility of Cell-free Next-generation Sequencing, Single Center Experience (2025)
Authors: O Ibrahim, R Rogers, D Farmakiotis
Citation: Open Forum Infectious Diseases 12 (Supplement_1), ofae631. 2321

3️⃣ Antimicrobial Resistance among Gram-negative Urinary Isolates from Kidney Transplant Recipients: Implications for Precision Antimicrobial Stewardship (2025)
Authors: A London, D Farmakiotis, KM Vieira, R Rogers, Y Shi
Citation: Open Forum Infectious Diseases 12 (Supplement_1), ofae631. 1732

4️⃣ Correction: Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis (2025)
Authors: F Shirazi, D Farmakiotis, Y Yan, N Albert, D Kim-Anh, DP Kontoyiannis
Citation: PloS One 20 (1), e0317530

5️⃣ Perceptions of COVID-19 Vaccination among Organ Transplant Recipients (2024)
Authors: R Lerner, P Arvanitis, D Guermazi, D Farmakiotis
Citation: Transplantation Proceedings 56 (8), 1861-1869

6️⃣ Medical Malpractice in Organ Transplantation: Public Allegations and Key Legal Outcomes (2024)
Authors: P Arvanitis, MR Davis, A London, D Farmakiotis
Citation: Frontiers in Health Services 4, 1408934

7️⃣ The Impact of Cancer Metastases on COVID‐19 Outcomes: A COVID‐19 and Cancer Consortium Registry‐Based Retrospective Cohort Study (2024)
Authors: CA Castellano, T Sun, D Ravindranathan, C Hwang, N Balanchivadze, D Farmakiotis
Citation: Cancer 130 (12), 2191-2204

8️⃣ Progressive Multifocal Leukoencephalopathy Unmasked by Teclistamab in a Refractory Multiple Myeloma Patient (2024)
Authors: P Arvanitis, D Farmakiotis, A Pelcovits
Citation: Current Oncology 31 (5), 2670-2678

9️⃣ Using a Commercially Available Assay That Measures Cytomegalovirus (CMV)-Specific CD4+ and CD8+ T-cell Immunity to Predict Protection Against CMV (2023)
Authors: NK Almaghlouth, P Arvanitis, K Vieira, D Farmakiotis
Citation: Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 697

🔟 Nirmatrelvir/Ritonavir Use Among Patients with Cancer and COVID-19 is Associated with Improved Clinical Outcomes: Single-Institution Case-Control Study (2023)
Authors: P Arvanitis, K Vieira, JL Warner, D Farmakiotis
Citation: Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 577

Conclusion

Dr. Farmakiotis is an exceptional candidate for the Best Researcher Award, given his high-impact research, clinical expertise, mentorship, and leadership roles. While he could expand into broader infectious disease research and secure more independent funding, his current contributions and recognitions make him a strong contender for this award.